semaglutide for type 1 diabetes and tirzepatide treatment leads to weight loss in Study Suggests Semaglutide Increases Insulin
Description
Thinking of switching from Mounjaro to Wegovy

Wegovy) and tirzepatide (Mounjaro

GLP-1 weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, researchers wrote in a new study.

This has prompted exploration of SGLT2 inhibitors in combination with other agents acting via decreased food intake, e.g., glucagon-like peptide 1 receptor agonists (GLP1-RAs)

PDF | Metabolic disorders such as obesity and diabetes are influenced by glucagon-like peptide-1 (GLP-1), which regulates insulin secretion
